ABT-719

DRUG2 trials

Sponsors

AbbVie

Conditions

Acute Kidney InjuryCardiothoracic SurgeryVascular Surgery

Phase 2

A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Cardiac Surgery

CompletedNCT01777165

AbbVieAcute Kidney Injury

Start: 2013-02-28End: 2014-03-31Updated: 2021-07-07

A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Surgery

TerminatedNCT01897519

AbbVieCardiothoracic Surgery, Vascular Surgery

Start: 2013-05-31End: 2014-05-31Updated: 2014-06-06

Related Papers

ABT‐719 for the Prevention of Acute Kidney Injury in Patients Undergoing High‐Risk Cardiac Surgery: A Randomized Phase 2b Clinical Trial

Journal of the American Heart Association2016-08-0840 citations